EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

American Lung Association Pulmonary Hypertension Roundtable: Executive Summary

Nicholas Andreas Kolaitis, Sandeep Sahay, Erika Berman Rosenzweig, Deborah Brown, Anna Hemnes, Elizabeth Joseloff, Joy Meyer, Karen A Pescatore, Albert Rizzo, Namita Sood, Bev Stewart, Vallerie McLaughlin und 2 weitere

Pulmonary Circulation · 2025-10 · 15 (4)

DOI: 10.1002/pul2.70200 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pulmonary Circulation, online erschienen am 14.11.2025. Verfasst von Nicholas Andreas Kolaitis und 13 weiteren Autor:innen. Beteiligte Einrichtung: Deparment of Medicine University of Californian San Francisco School of Medicine San Francisco California USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The American Lung Association and Pulmonary Hypertension Association convened a scientific roundtable of pulmonary hypertension experts to discuss the latest recommendations from the European Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension (PH) and from the 7th World Symposium on Pulmonary Hypertension (WSPH). The aim of the roundtable was to discuss changes that were made compared to earlier recommendations and guidelines set out by the European Society of Cardiology and the European Respiratory Society in 2015, the 6th World Symposium on Pulmonary Hypertension in 2018, and the CHEST Guideline on Therapy for Pulmonary Arterial Hypertension in 2019. The overall objectives were to: 1) Create an educational resource for providers that summarizes currently available PAH guidelines, 2) Provide an expert critique of current guidelines, outlining strengths and weaknesses and resolving differences where guidelines do not agree. 3) Provide guidance for the incorporation of the recently approved drug, sotatercept into current guidelines. An executive summary was drafted following the roundtable meeting on April 8, 2024, and revised by the panel in September 2024, following publication of the proceedings from the 7th WSPH held in Barcelona June 29‐July 1, 2024. The Executive Summary reviews changes to the hemodynamic criteria for defining pre‐ and post‐capillary PH, exercise‐induced PH, and PH associated with lung disease. Recommendations are given for proper diagnosis and clinical classifications of the various forms of PH. The role of screening for PH in high‐risk populations and the use of risk scores for disease stratification are discussed. Finally, treatment algorithms for managing pulmonary arterial hypertension, PH associated with lung disease, and chronic thromboembolic pulmonary hypertension are presented.

Schlagwörter

Stichwörter der Autor:innen

pharmacologic therapypulmonary arterial hypertensiontreatment guidelines

Autor:innen und Institutionen

  • Deparment of Medicine University of Californian San Francisco School of Medicine San Francisco California USA.
  • Division of Pulmonary Critical Care & Sleep Medicine, Houston Methodist Hospital Houston Texas USA.
  • Department of Pediatrics Westchester Medical Center, New York Medical College Valhalla New York USA.
  • American Lung Association Chicago Illinois USA.
  • Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine Vanderbilt University Nashville Tennessee USA.
  • Pulmonary Hypertension Association Washington District of Columbia USA.

ORCID-Profile: James R Klinger

Zitieren

APA

Kolaitis, N. A., Sahay, S., Rosenzweig, E. B., Brown, D., Hemnes, A., Joseloff, E., Meyer, J., Pescatore, K. A., Rizzo, A., Sood, N., Stewart, B., McLaughlin, V., Williamson, T., & Klinger, J. R. (2025). American Lung Association Pulmonary Hypertension Roundtable: Executive Summary. Pulmonary Circulation, 15(4). https://doi.org/10.1002/pul2.70200

Vancouver

Kolaitis NA, Sahay S, Rosenzweig EB, Brown D, Hemnes A, Joseloff E, et al. American Lung Association Pulmonary Hypertension Roundtable: Executive Summary. Pulmonary Circulation. 2025;15(4). doi:10.1002/pul2.70200

BibTeX
@article{Kolaitis2025,
  author = {Kolaitis, Nicholas Andreas and Sahay, Sandeep and Rosenzweig, Erika Berman and Brown, Deborah and Hemnes, Anna and Joseloff, Elizabeth and Meyer, Joy and Pescatore, Karen A and Rizzo, Albert and Sood, Namita and Stewart, Bev and McLaughlin, Vallerie and Williamson, Tim and Klinger, James R},
  title = {American Lung Association Pulmonary Hypertension Roundtable: Executive Summary},
  journal = {Pulmonary Circulation},
  year = {2025},
  volume = {15},
  number = {4},
  doi = {10.1002/pul2.70200}
}
Kostenlos starten →